20 mg (303512 0b)
Hysingla Er Tablet, Extended Release
Product Images NDC 59011-271
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Hysingla Er (NDC 59011-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Knoa Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
30 mg (303513 0b)
40 mg (303514 0b)
60 mg (303515 0b)
80 mg (303516 0b)
This is not available. The text appears to be a random combination of alphanumeric characters, symbols, and gibberish words that cannot be used to generate a useful description.*
100 mg (303517 0b)
120 mg (303518 0b)
This is a pharmaceutical product with a National Drug Code of 59011-277-60. There is also a series of alphanumeric characters and numbers that do not provide any useful information that can be deciphered.*
Figure-1 (Figure 1)
Figure-2 (Figure 2)
Figure-3 (Figure 3)
This is a chart displaying plasma concentration levels (in ng/ml) of hydrocodone over a period of time (in hours). Two different types of medication were tested: Hysingla ER 30mg (taken once a day for 3 days) and IR Hydrosodore Bitatrate 7.5mg (taken once every 4 hours for 3 days). The chart shows the levels of both medications decreasing over time.*
Figure-4 (Figure 4)
Hydrocodone-bitartrate-structure (Hydrocodone Bitartrate Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
